UK 12:33 Friday, 16 October 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Full time trader and part time author Trader Ferg kicks off on emerging fuel shortages.
For starters as Bluebird (BMV) is running out of cash/has no cash a discounted placing is imminent. If it happens very soon the share sale by Skylake LLP ( wholly owned by its sole employee Sath Ganesarajah) will be reported to the FCA to add to its bulging file.
Yesterday Alessandro Zamboni's US bezzle Nuburu (US:BURU) announced that it had finally closed its acquisition of 70% of Tekne.
The CFO of Amaroq (AMRQ) has posted on LinkedIn about a meeting the Company has with the PMs of Greenland, Iceland and the Faroes about investment in Greenland. The US has hallmarked billons for critical metals investment in Greenland. Amaroq is a profitable company set to have 3 mines running within three years, a FTSE 250 stock going places. Yet it is letting itself down. I have written to CEO Eldur Olaffson.
Thor Explorations (THX) has issued a “Q3 2026 Operating Update” including “gold sales in Q3 of 19,000 oz at an average realised price of US$4,297… Q3 cash balance of US$224.9 million and gold bullion inventory of 2,825 oz for an adjusted net cash position of US$236.7 million”. How does the performance compare to the valuation at a 54p share price?
Sore heads are the order of the day for the nearly 1000 crony capitalists who swilled champagne, funded by mug punters like you and me, and ogled PR fluffies at the Annual black tie AIM Awards dinner. As they lived it up, apart from the 10 minutes of dozing as Marcus Stuttard gave a speech, more data finally emerges as to the dire state of the casino.
‘E-commerce’ Beauty and Nutrition group THG plc (THG) has issued a “Q3 2026 Trading Statement” headlined “Strong profitability momentum drives upgrade of FY26 Adjusted EBITDA expectations to £103m”. The shares have currently responded up to 32p, but is the underlying trading momentum as positive as the headline suggests?
I start with Prospex (PXEN), Charles Archer and Amaroq (AMRQ). Then it is Blackbird (BIRD), a detailed look at Mindflair (MFAI) where a placing today makes no sense to me at all. I really do not get it. Finally the scourge of forward selling, Predator (PRD) and a real challenge to the FCA.
Oh dear, it is bad news for Paul Mathieson whose membership of this website runs out at midnight tonight so whose days of posting defamatory and threatening comments not only about myself, my wife and son but also in recent days about readers are now drawing to a close.
Describing itself as “a leading provider of walk-through security technology”, Thruvision Group (THRU) has issued a “Multiple orders received”-titled announcement and that “these orders represent further progress across three important areas of the group’s strategy”; high-throughput distribution environments, the ‘Prisons and Corrections’ market and further international development. What’s the details of the orders, with the shares currently back up to above 2p in response?
Investor Jeff Phillips argues that the current pullback in precious metals and junior miners is a buying opportunity within a longer-term commodity super cycle driven by underinvestment, supply chain concerns, and inflationary currency debasement.
I have written to my contact at the FCA about today’s placing by Predator Oil & Gas (PRD) which looks to me to be the most blatantly forward sold placing this year. Forward selling is insider dealer and is illegal. It is also endemic on the London Small Cap scene and the FCA needs to act. I wrote to my FCA contact:
A reader whose opinion I respect writes to me about Prospex Energy (PXEN) and ramping by Charles Archer. I start with the comments from reader TP and then offer a few thoughts of my own. Suffice to say that at 6.2p, a £27 million market cap, the shares are a screaming sell as, by my maths, all the money’s gone and a placing is imminent. A reader writes:
Most recently on company describing itself as “specialists in pre-clinical antibody discovery, engineering and supply” Fusion Antibodies (FAB), last month with the shares falling below 10p I concluded, with the financial position, an approx. £12 million market cap still sell. The shares most recently closed at 9.75p and what about now an “AGM statement H1 trading and research update” announcement?
I have written to my contact at the FCA & to the Oxymorons at AIM Regulation requesting a formal investigation into what looks like a clear case of forward selling/insider dealing ahead of thus week’s placing by Energy Pathways (EPP). I write to my contact:
